Search
Idursulfase
go.drugbank.com/drugs/DB01271ApprovedInvestigationalIdursulfase is a purified form of human iduronate-2-sulfatase, a lysosomal enzyme. Idursulfase is produced by recombinant DNA technology in a human cell line. Idursulfase is an enzyme that hydrolyzes the 2-sulfate esters of terminal idur...
Products: ELAPRASE 2 MG/ML İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 1 ADET, Elaprase (TM) Solution for Intravenous Infusion 2mg/ mlTuroctocog alfa
go.drugbank.com/drugs/DB09109ApprovedTuroctocog alfa is a recombinant factor VIII (rFVIII) with a truncated B-domain made from the sequence coding for 10 amino acids from the N-terminus and 11 amino acids from the C-terminus of the naturally … [A31504] It was developped by Novo Nordisk and FDA approved in October 16, 2013.[L1104]
Products: โนโวเอท 500 หน่วยสากล, NOVOEIGHT®1000 UI POLVO Y SOLVENTE PARA SOLUCIÓN INYECTABLEConjugated estrogens
go.drugbank.com/drugs/DB00286ApprovedInvestigational[L5605, T475] The conjugated estrogen product contains a mix of estrogen from which about 50% is represented by estrone sulfate followed by 25% of equilin sulfate, 15% of 17-alpha-dehydroequilenin … sulfate, 3% of equilenin sulfate, 5% of 17-alpha and 17-beta-dihydroequilenin sulfate, 2% of 17-alpha-estradiolsulfate and 3% of 17-beta-estradiolsulfate.
Mixtures: DUAVİVE 0.45 MG/20 MG DEĞİŞTİRİLMİŞ SALIMLI TABLET, 30 TABLET, DUAVIVE 20 mg/0.45 mg modified - release tabletsCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 InhibitorsCarbidopa
go.drugbank.com/drugs/DB00190ApprovedInvestigational[T394] The first approved product by the FDA containing only carbidopa was developed by Amerigens Pharmaceuticals Ltd and approved on 2014. … An individual formulation containing solely carbidopa was generated to treat nausea in patients where the combination therapy [levodopa]/carbidopa is not efficient reducing nausea.
Mixtures: ANTIPAR 200 MG/50 MG/200 MG FILM KAPLI TABLET, 100 ADET, ANTIPAR 50 MG/ 12,5 MG/ 200 MG FİLM KAPLI TABLET, 100 ADETProducts: Carbidopa Tablets, 25 mgPentostatin
go.drugbank.com/drugs/DB00552ApprovedInvestigationalIt is also synergistic with some other antineoplastic agents and has immunosuppressive activity.
Products: CIPROFLOXACINO TABLETAS RECUBIERTAS 500 MG.Ceftazidime
go.drugbank.com/drugs/DB00438ApprovedInvestigationalBacteria possess a cell wall comprising a glycopeptide polymer commonly known as peptidoglycan, which is synthesized and remodelled through the action of a family of enzymes known as "penicillin-binding … [A232920, A232925, A232930] Ceftazidime is a third-generation cephalosporin with broad-spectrum antibacterial activity, including against some treatment-resistant bacteria such as _Pseudomonas aeruginosa
Mixtures: ZAVİCEFTA 2 G/0.5 G İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 10 ADET, CEFAZIME FOR INJECTION 1 g/vialProducts: Kefazim 500 mg Trockenstechampulle, Ceftazidim Astro 500 mg Pulver zur Herstellung einer InjektionslösungPhenoxybenzamine
go.drugbank.com/drugs/DB00925ApprovedInvestigationalIt has been used to treat hypertension and as a peripheral vasodilator.
Products: Dibenzyran 10 mg KapselnDacomitinib
go.drugbank.com/drugs/DB11963ApprovedInvestigational[A40009] Dacomitinib was developed by Pfizer Inc and approved by the FDA on September 27, 2018. … Dacomitinib, designed as (2E)-N-16-4-(piperidin-1-yl) but-2-enamide, is an oral highly selective quinazalone part of the second-generation tyrosine kinase inhibitors which are characterized by the irreversible
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 SubstratesProducts: VİZİMPRO 30 MG FİLM KAPLI TABLET, 30 ADET, Vizimpro 30 mg Film-Coated TabletsClodronic acid
go.drugbank.com/drugs/DB00720ApprovedInvestigationalVet approved[A1923] clodronate’s use has decreased over the years in favor of the third generation, nitrogen containing bisphosphonate [zoledronic acid], [ibandronic acid], [minodronic acid], and [risedronic acid]
Synonyms: PHOSPHONIC ACID, (DICHLOROMETHYLENE)BIS-Products: BONEFOS 800 MG TABLET, 60 ADET, Lodronat 520 mg - FilmtablettenClevidipine
go.drugbank.com/drugs/DB04920ApprovedInvestigationalClevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InducersProducts: Cleviprex 0,5 mg/ml Emulsion zur Injektion